X0306 4 2015-03-02 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001502213 Chai-Onn Robert Roswell 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, CLO, General Counsel Common Stock, no par value 2015-03-02 4 M 0 90939 25.42 A 112296 D Common Stock, no par value 2015-03-02 4 S 0 90939 200.0142 D 21379 D Common Stock, no par value 2015-03-03 4 M 0 21808 6.1 A 43187 D Non-Qualified Stock Options (right to purchase) 25.42 2015-03-02 4 M 0 90939 0 D 2014-10-08 2015-11-11 Common shares, no par value 90939 90938 D Non-Qualified Stock Options (right to purchase) 6.1 2015-03-03 4 M 0 21808 0 D 2009-11-01 2015-11-01 Common shares, no par value 21808 21807 D This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 11, 2015. This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold, in each case pursuant to a 10b5-1 trading plan. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. This number represents options exercised and held pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 1, 2015. The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the vesting commencement date, the second vest date falling on the second anniversary of the vesting commencement date, the third vest date falling on the third anniversary of the vesting commencement date, and the fourth vest date falling on the fourth anniversary of the vesting commencement date. by: Nicholas Zanoni for Robert Chai-Onn 2015-03-04